Stanford Medicine researchers have achieved significant success in mitigating the enduring effects of Traumatic Brain Injury (TBI) in military veterans by employing the plant-based psychoactive drug ibogaine, complemented by magnesium for heart protection. A recent study, featured in Nature Medicine, outlines the positive outcomes observed in 30 U.S. special forces veterans subjected to this innovative treatment.
TBI, resulting from head trauma or blast explosions, often contributes to post-traumatic stress disorder (PTSD), anxiety, depression, and increased suicide rates among veterans. The study, led by Dr. Nolan Williams, Associate Professor of Psychiatry and Behavioral Sciences, demonstrated that ibogaine, sourced from the African shrub iboga, effectively reduces PTSD, anxiety, and depression while enhancing overall functioning in veterans.
Before the study, participants, experiencing clinically severe psychiatric symptoms and functional disabilities, underwent measurement assessments. Ibogaine treatment, administered in tandem with magnesium, yielded remarkable improvements, persisting for at least one month post-treatment.
The veterans, initially reporting mild to moderate disability, achieved a disability rating indicating no disability one month after ibogaine treatment. Notably, the study participants experienced substantial reductions in PTSD (88%), depression (87%), and anxiety symptoms (81%). Cognitive testing also revealed enhanced concentration, information processing, memory, and impulsivity.
The study marks a breakthrough in TBI treatment, offering hope to veterans grappling with debilitating neuropsychiatric symptoms. The absence of serious side effects further underscores the potential therapeutic benefits of ibogaine. Researchers, led by Dr. Williams, plan to conduct further analysis, including brain scans, to explore the drug's broader neuro-rehabilitative potential beyond TBI, extending to conditions like PTSD, anxiety, and depression. The study was independently funded by philanthropists Steve and Genevieve Jurvetson.
Source: Williams, Sarah. Stanford Medicine. "Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets". https://med.stanford.edu/news/all-news/2024/01/ibogaine-ptsd.html. 05/01/2024. [Date accessed: 06/01/2024]
Edited by: Aditya Vinjimoor
Comentarios